Prokidney Corp (PROK)

Mar 17, 2025, 7:30 AM EDT - 5 weeks ago

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Mar 13, 2025, 7:06 AM EDT - 6 weeks ago

Top 3 Health Care Stocks You'll Regret Missing This Quarter

RDNT TCMD

Jan 31, 2025, 11:08 AM EST - 3 months ago

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

Jan 31, 2025, 6:10 AM EST - 3 months ago

2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment

Nov 26, 2024, 7:30 AM EST - 5 months ago

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

Nov 12, 2024, 7:30 AM EST - 5 months ago

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

Nov 5, 2024, 7:30 AM EST - 6 months ago

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

Oct 14, 2024, 7:30 AM EDT - 6 months ago

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

Oct 9, 2024, 7:30 AM EDT - 7 months ago

ProKidney to Participate in the UBS Virtual Organ Restoration Day

Sep 3, 2024, 7:30 AM EDT - 8 months ago

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

Aug 27, 2024, 7:30 AM EDT - 8 months ago

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 9, 2024, 7:00 AM EDT - 9 months ago

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

Jun 11, 2024, 9:35 PM EDT - 11 months ago

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 4:15 PM EDT - 11 months ago

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 6:30 AM EDT - 11 months ago

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

May 29, 2024, 7:00 AM EDT - 11 months ago

ProKidney to Participate in the Jefferies Global Healthcare Conference

May 21, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

May 10, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

Mar 25, 2024, 6:05 AM EDT - 1 year ago

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Mar 21, 2024, 7:49 PM EDT - 1 year ago

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Feb 29, 2024, 4:05 PM EST - 1 year ago

ProKidney to Participate in Jefferies Biotech on the Bay Summit

Nov 30, 2023, 6:05 AM EST - 1 year ago

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

Nov 21, 2023, 6:05 AM EST - 1 year ago

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

Nov 16, 2023, 4:40 PM EST - 1 year ago

ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 6:05 AM EST - 1 year ago

ProKidney Reports Third Quarter Financial Results

Nov 13, 2023, 5:02 PM EST - 1 year ago

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

Oct 30, 2023, 4:12 PM EDT - 1 year ago

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

Sep 5, 2023, 6:05 AM EDT - 1 year ago

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

Aug 10, 2023, 4:10 PM EDT - 1 year ago

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

Jul 18, 2023, 6:05 AM EDT - 1 year ago

ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC

Jul 15, 2023, 2:02 AM EDT - 1 year ago

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization

Jun 13, 2023, 12:05 PM EDT - 2 years ago

ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC

Jun 1, 2023, 4:05 PM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

May 11, 2023, 4:01 PM EDT - 2 years ago

ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights

May 4, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Present at the BofA Securities Health Care Conference 2023

Apr 12, 2023, 11:51 AM EDT - 2 years ago

ProKidney: Too Many Billionaires, Too Little Data

Mar 28, 2023, 4:12 PM EDT - 2 years ago

ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights

Mar 3, 2023, 6:05 AM EST - 2 years ago

ProKidney to Participate in TD Cowen's 43rd Annual Health Care Conference

Jan 11, 2023, 7:48 AM EST - 2 years ago

ProKidney's stock jumps 29%

Jan 10, 2023, 4:05 PM EST - 2 years ago

ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease

Dec 22, 2022, 6:05 AM EST - 2 years ago

ProKidney to Present at the J.P. Morgan 41st Annual Healthcare Conference

Nov 14, 2022, 6:05 AM EST - 2 years ago

ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights

Nov 11, 2022, 4:05 PM EST - 2 years ago

ProKidney to Participate in Upcoming Investor Conferences

Nov 3, 2022, 6:05 AM EDT - 2 years ago

ProKidney Receives Allowance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for proact 1 (REGEN-006) and EMA Scientific Advice on Phase 3 Protocols of REACT for Diabetic Chronic Kidney Disease

Oct 14, 2022, 12:00 PM EDT - 2 years ago

ProKidney Announces Multiple Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2022

Sep 23, 2022, 6:15 AM EDT - 2 years ago

ProKidney to Present at the Jefferies Cell and Genetic Medicine Summit

Sep 8, 2022, 6:05 AM EDT - 2 years ago

ProKidney to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Aug 31, 2022, 6:05 AM EDT - 2 years ago

ProKidney Appoints Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations

Aug 11, 2022, 5:30 PM EDT - 2 years ago

ProKidney Corp. Reports Second Quarter 2022 Financial Results and Provides Business Update

Aug 11, 2022, 10:01 AM EDT - 2 years ago

ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox